Pancreatic Cancer Research

ResearcherHamamatsu UniversityActive in the last 2 years

Yoshifumi Morita

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6940-2487; OpenAlex author ID A5083529139. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. SPARC is associated with tumor nerve stroma interactions and perineural invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-026-51848-6↗
  2. Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy. Co-author DOI 10.1080/07853890.2024.2398725↗
  3. Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibi… First author PMID 38058842↗
  4. Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis. Co-author DOI 10.1002/jhbp.1127↗
  5. Ephrin Receptor A4 Expression Enhances Migration, Invasion and Neurotropism in Pancreatic Ductal Adenocarcinoma Cells. First author DOI 10.21873/anticanres.14938↗
  6. Tenascin C in the Tumor-Nerve Microenvironment Enhances Perineural Invasion and Correlates With Locoregional Recurrence in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001506↗
  7. Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor. Co-author DOI 10.1159/000508439↗
  8. Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer. Co-author DOI 10.1186/s12885-019-5621-5↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Satoru Furuhashi · 7 shared papers, 2019–2026 · strength 1.04
  2. Hiroya Takeuchi · 6 shared papers, 2019–2026 · strength 0.88
  3. Takafumi Suda · 1 shared paper, 2024 · strength 0.17
  4. Kensuke Kitsugi · 1 shared paper, 2024 · strength 0.17
  5. Koji Ikegami · 1 shared paper, 2020 · strength 0.11
  6. Yuzo Yamamoto · 1 shared paper, 2022 · strength 0.11
  7. Masakazu Yamamoto · 1 shared paper, 2022 · strength 0.11
  8. Yuki Homma · 1 shared paper, 2022 · strength 0.11
  9. Yasuji Seyama · 1 shared paper, 2022 · strength 0.11
  10. Kazuhiro Yoshida · 1 shared paper, 2022 · strength 0.11
  11. Shugo Mizuno · 1 shared paper, 2022 · strength 0.11
  12. Masayuki Sho · 1 shared paper, 2022 · strength 0.11
  13. Hiroki Yamaue · 1 shared paper, 2022 · strength 0.11
  14. Yutaka Takeda · 1 shared paper, 2022 · strength 0.11
  15. Yuko Mataki · 1 shared paper, 2022 · strength 0.11
  16. Masaji Tani · 1 shared paper, 2022 · strength 0.11
  17. Satoshi Hirano · 1 shared paper, 2022 · strength 0.11
  18. Toshiki Rikiyama · 1 shared paper, 2022 · strength 0.11
  19. Hideo Baba · 1 shared paper, 2022 · strength 0.11
  20. Itaru Endo · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.